The association between paraneoplastic neurological syndromes (PNS) and urothelial carcinoma - A review of the literature
- PMID: 38447785
- DOI: 10.1016/j.critrevonc.2024.104314
The association between paraneoplastic neurological syndromes (PNS) and urothelial carcinoma - A review of the literature
Abstract
Paraneoplastic neurological syndromes (PNS) are rare neurological disorders arising from malignancy-triggered autoimmunity, yet their association with urothelial carcinoma remains unclear. This systematic review intends to explore any connection, alongside patient/clinical features and management. A literature search identified 25 cases of bladder and upper tract carcinoma linked to PNS. Overall, while infrequent, a meaningful association between PNS and urothelial carcinoma was found in that 84% of cases met a 'possible'-or-'higher-likelihood' PNS diagnosis. Most cases presented with high-risk PNS phenotypes, predominantly cerebellar syndromes and encephalomyelitis/sensory neuronopathy, ∼17 months within cancer diagnosis/recurrence. Review findings suggest a female preponderance in suspected PNS despite higher male incidence of urothelial cancer. Main treatments consisted of surgery alongside chemotherapy or immunotherapeutics (IVIG and/or corticosteroids), which improved symptoms for a slight majority (60%). Ultimately, while common PNS-associated neoplasms should always first be excluded in suspected PNS, in the absence of alternative causes, urothelial carcinomas do merit clinical consideration.
Keywords: Bladder cancer; PNS; Paraneoplastic neurological syndromes; Transitional cell carcinoma; Upper tract urothelial carcinoma; Urothelial carcinoma.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.J Neurol. 2023 Jan;270(1):283-299. doi: 10.1007/s00415-022-11356-9. Epub 2022 Sep 1. J Neurol. 2023. PMID: 36050418
-
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.Eur Urol. 2017 Apr;71(4):545-557. doi: 10.1016/j.eururo.2016.09.035. Epub 2016 Oct 6. Eur Urol. 2017. PMID: 27720534 Free PMC article.
-
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors.Eur Urol Oncol. 2022 Feb;5(1):30-41. doi: 10.1016/j.euo.2021.11.001. Epub 2021 Dec 9. Eur Urol Oncol. 2022. PMID: 34896051
-
Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.Eur Urol. 2022 Aug;82(2):182-192. doi: 10.1016/j.eururo.2022.03.027. Epub 2022 Apr 5. Eur Urol. 2022. PMID: 35393159
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous